6755 related articles for article (PubMed ID: 2418160)
1. Comparative studies of ampligen (mismatched double-stranded RNA) and interferons.
Carter WA; Hubbell HR; Krueger LJ; Strayer DR
J Biol Response Mod; 1985 Dec; 4(6):613-20. PubMed ID: 2418160
[TBL] [Abstract][Full Text] [Related]
2. Preclinical studies with Ampligen (mismatched double-stranded RNA).
Carter WA; Strayer DR; Hubbell HR; Brodsky I
J Biol Response Mod; 1985 Oct; 4(5):495-502. PubMed ID: 4078595
[TBL] [Abstract][Full Text] [Related]
3. Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft.
Hubbell HR; Pequignot EC; Todd J; Raymond LC; Mayberry SD; Carter WA; Strayer DR
J Biol Response Mod; 1987 Oct; 6(5):525-36. PubMed ID: 3681346
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.
Hubbell HR; Pequignot EC; Shanabrook KR; Carter WA; Williams RD; Strayer DR
Anticancer Res; 1990; 10(3):795-801. PubMed ID: 2369093
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies with ampligen (mismatched double-stranded RNA).
Brodsky I; Strayer DR; Krueger LJ; Carter WA
J Biol Response Mod; 1985 Dec; 4(6):669-75. PubMed ID: 4087035
[TBL] [Abstract][Full Text] [Related]
6. Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.
Dick RS; Hubbell HR
J Neurooncol; 1987; 5(4):331-8. PubMed ID: 2450181
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antiproliferative effect of human interferons in combination with mismatched double-stranded RNA on human tumor cells.
Hubbell HR
Int J Cancer; 1986 Mar; 37(3):359-65. PubMed ID: 2419265
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and immunomodulatory actions of beta-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice.
Hubbell HR; Kvalnes-Krick K; Carter WA; Strayer DR
Cancer Res; 1985 Jun; 45(6):2481-6. PubMed ID: 3986788
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effect of mismatched double-stranded RNA on fresh human tumor cells analyzed in a clonogenic assay.
Strayer DR; Watson P; Carter WA; Brodsky I
J Interferon Res; 1986 Aug; 6(4):373-9. PubMed ID: 3772178
[TBL] [Abstract][Full Text] [Related]
10. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
Hubbell HR; Liu RS; Maxwell BL
Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
Sidky YA; Borden EC
Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.
Hubbell HR; Boyer JE; Roane P; Burch RM
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):906-10. PubMed ID: 1846967
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
Geiger T; Müller M; Monia BP; Fabbro D
Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
[TBL] [Abstract][Full Text] [Related]
14. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
Ohmura K; Tsukamoto T
Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
17. Growth of astrocytomas in the human tumor clonogenic assay and sensitivity to mismatched dsRNA and interferons.
Strayer DR; Weisband J; Carter WA; Black P; Nidzgorski F; Cook AW
Am J Clin Oncol; 1987 Aug; 10(4):281-4. PubMed ID: 3039828
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of Ampligen.
Brodsky I; Strayer DR
Am Fam Physician; 1987 Oct; 36(4):253-6. PubMed ID: 3673869
[No Abstract] [Full Text] [Related]
19. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
[TBL] [Abstract][Full Text] [Related]
20. [Interferons in the treatment of solid tumors. A general review].
Dorval T; Pouillart P
Bull Cancer; 1988; 75(9):885-8. PubMed ID: 2462946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
